Literature DB >> 12043694

Transjugular intrahepatic portosystemic shunt for treatment of portal hypertension due to extramedullary hematopoiesis in idiopathic myelofibrosis.

Bernhard Angermayr, Manfred Cejna, Maria Schoder, Fritz Wrba, Peter Valent, Alfred Gangl, Markus Peck-Radosavljevic.   

Abstract

Entities:  

Mesh：

Year:  2002        PMID： 12043694     DOI： 10.1182/blood-2002-01-0282

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  Synergism between hepatocellular injury and shunting in portosystemic encephalopathy (PSE): case report of acute brittle TIPS-induced PSE.

Authors:  Gil Weitzman; Neil J Schamberg; Gerond Lake-Bakaar
Journal:  Dig Dis Sci       Date:  2007-07-20       Impact factor: 3.199

Review 2.  Current use of transjugular intrahepatic portosystemic shunts.

Authors:  Timothy M McCashland
Journal:  Curr Gastroenterol Rep       Date:  2003-02

3.  Child-Pugh versus MELD score in predicting survival in patients undergoing transjugular intrahepatic portosystemic shunt.

Authors:  B Angermayr; M Cejna; F Karnel; M Gschwantler; F Koenig; J Pidlich; H Mendel; L Pichler; M Wichlas; A Kreil; M Schmid; A Ferlitsch; E Lipinski; H Brunner; J Lammer; P Ferenci; A Gangl; M Peck-Radosavljevic
Journal:  Gut       Date:  2003-06       Impact factor: 23.059

4.  Portal hypertension complicating myelofibrosis in a patient without portal or hepatic vein thrombosis.

Authors:  Xingshun Qi; Jia Jia; Ming Bai; Daiming Fan; Guohong Han
Journal:  Ann Gastroenterol       Date:  2014
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.